OncologyPhase 2APPAHOCA-2NCT06201884
Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery
A Phase 2 study testing Early rehabilitation through Adapted Physical Activity in people with Oncology and Elderly Patients, run by Centre Francois Baclesse at 2 sites in France.
Trial summary
The aim of this study was to evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Oncology, Elderly Patients, Surgery
- What is being tested?
- Early rehabilitation through Adapted Physical Activity
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 2 sitesFrance
- Study dates
- 15 Mar 2024to Dec 2027
- Phase
- Phase 2
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Men or women aged 65 or over
- Candidate for scheduled major oncological surgery and/or surgery with high morbidity
- Patient able to walk for 10 minutes on the walking platform at the time of the test
- Patient affiliated to a social security system
- Signature of informed consent prior to any specific study-related procedure
Who cannot join
- Patient with severe undernutrition (BMI<18, and/or weight loss >15% in 6 months or >10% in 1 month)
- Emergency surgery
- Physical contraindications preventing use of the platform
- Simultaneous participation in another clinical study that could compromise the conduct of this study
- Patients deprived of their liberty, under guardianship or subject to a legal protection measure, or unable to express their consent.
- Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
France2 sites, 2 recruiting
- Recruiting
Centre Francois Baclesse
Caen
Heidi LAVIEC, MD, h.laviec@baclesse.unicancer.fr
- Recruiting
CHU CAEN
Caen
Bérengère BEAUPLET, MD, b.beauplet@chu-caen.fr
About this study
The aim of this study was to evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.
- Conditions
- Oncology, Elderly Patients, Surgery
- Being tested
- Early rehabilitation through Adapted Physical Activity
- Keywords
- Adapted physical activity, walking platform
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Early rehabilitation through Adapted Physical ActivityDevice
From the day after surgery, 1 to 2 walking sessions with walking platform, lasting 6 to 30 minutes (min-max), will be proposed daily until the day of discharge.
| Study group | Role | What they receive |
|---|---|---|
| Adapted physical activity | Experimental | Adapted physical activity on a walking platform Receives: Device: Early rehabilitation through Adapted Physical Activity |
What is being measured
The primary outcome is the main question the study is designed to answer.
To evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.
Proportion of patients having recovered their preoperative walking speed at hospital discharge
Measured: at hospital discharge (approximately 15 to 30 days after surgery)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jan 2024
- Study start15 Mar 2024
- Primary completionDec 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OncologyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Francois Baclesse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06201884
- Sponsor's protocol ID
- 2023-A01292-43
- Acronym
- APPAHOCA-2
- Status last verified
- Jan 2026
- First submitted
- 2 Jan 2024
- Last updated
- 12 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 12 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery
- ClinicalTrials.gov ID
- NCT06201884
- Acronym / sponsor ID
- APPAHOCA-2 / 2023-A01292-43
- Conditions
- Oncology, Elderly Patients, Surgery
- Keywords
- Adapted physical activity, walking platform
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Centre Francois BaclesseUniversity, hospital or other
- Study start
- 15 Mar 2024 (actual)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 11 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study was to evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Adapted physical activity | Experimental | Device: Early rehabilitation through Adapted Physical ActivityAdapted physical activity on a walking platform |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (5 listed)
- Men or women aged 65 or over
- Candidate for scheduled major oncological surgery and/or surgery with high morbidity
- Patient able to walk for 10 minutes on the walking platform at the time of the test
- Patient affiliated to a social security system
- Signature of informed consent prior to any specific study-related procedure
Key exclusion criteria (6 listed)
- Patient with severe undernutrition (BMI<18, and/or weight loss >15% in 6 months or >10% in 1 month)
- Emergency surgery
- Physical contraindications preventing use of the platform
- Simultaneous participation in another clinical study that could compromise the conduct of this study
- Patients deprived of their liberty, under guardianship or subject to a legal protection measure, or unable to express their consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Early rehabilitation through Adapted Physical ActivityFrom the day after surgery, 1 to 2 walking sessions with walking platform, lasting 6 to 30 minutes (min-max), will be proposed daily until the day of discharge. | Device | Adapted physical activity |
Primary outcome
To evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older.
Time frame: at hospital discharge (approximately 15 to 30 days after surgery)
Proportion of patients having recovered their preoperative walking speed at hospital discharge
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jan 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Oncology
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Early rehabilitation through Adapted Physical Activity in people with Oncology and Elderly Patients, run by Centre Francois Baclesse at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Heidi LAVIEC, MD (0231455050, h.laviec@baclesse.unicancer.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To evaluate the efficacy of daily use of a walking platform to improve recovery of preoperative walking speed at hospital discharge following oncological surgery in patients aged 65 or older. (time frame: at hospital discharge (approximately 15 to 30 days after surgery)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026.